GE vs MRK: Which Is the Better Buy?
Side-by-side comparison of GE Aerospace and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-16.
GE Aerospace · Industrials
$360.35
-25.9% upside to fair value
Grade D
High Quality
VS
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
QuantHub Verdict
MRK has more upside to fair value
(-12.1%).
MRK trades at a lower forward P/E
(32.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
GE |
MRK |
| Current Price |
$360.35 |
$113.87 |
| Fair Value Estimate |
$267.03 |
$100.14 |
| Upside to Fair Value |
-25.9%
|
-12.1%
|
| Market Cap |
$376.5B |
$281.2B |
| Forward P/E |
42.3x
|
32.0x
|
| EV / EBITDA |
33.4x
|
17.3x
|
| Price / Sales |
7.8x
|
4.3x
|
| Price / FCF |
50.5x
|
19.9x
|
| Revenue Growth YoY |
+21.1%
|
+4.3%
|
| Gross Margin |
36.1%
|
75.9%
|
| Operating Margin |
21.0%
|
27.6%
|
| Return on Equity |
46.2%
|
17.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.98%
|
5.02%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
GE Aerospace operates in the Industrials sector within the Aerospace & Defense industry, delivering high-quality aerospace products and services. The business demonstrates strong fundamentals with a high return on equity of 46.2%, robust revenue growth of 21.1% in the most recent quarter, and solid earnings growth of 16.9% in the same period. Margins are healthy, with a gross margin of 36.1%, ope…
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Accumulation Zones
| Metric |
GE |
MRK |
| Zone Low |
$200.27 |
$75.11 |
| Zone High |
$226.98 |
$85.12 |
| In Buy Zone? |
No
|
No
|